Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339545 · ClinicalTrials.gov registry record
Coronary Flow Reserve Following Orbital Atherectomy
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 15
- Enrollment target
NCT02339545 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 15 participants.
The verdict
NCT02339545 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of the study was to evaluate coronary artery flow reserve (CFR) following successful percutaneous coronary intervention (PCI) treatment of severely calcified coronary lesions by orbital atherectomy and stenting.
Interventions
- DEVICE Coronary Orbital Atherectomy plus Stenting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02339545
The ClinicalTrials.gov registry entry for NCT02339545 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coronary Orbital Atherectomy plus Stenting is the first listed.
NCT02339545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02339545 about?
NCT02339545 is a clinical study titled "Coronary Flow Reserve Following Orbital Atherectomy". The purpose of the study was to evaluate coronary artery flow reserve (CFR) following successful percutaneous coronary intervention (PCI) treatment of severely calcified coronary lesions by orbital atherectomy and stenting.
What is the current status of trial NCT02339545?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2015-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02339545?
The interventions under investigation include: Coronary Orbital Atherectomy plus Stenting (DEVICE).
Who is sponsoring clinical trial NCT02339545?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.